FibroGen (FGEN) Reaches $43.85 After 7.00% Down Move; Profile of 10 Analysts Covering Go-Ahead Group plc (LON:GOG)

November 14, 2017 - By Peter Kolinski

Among 15 analysts covering Go-Ahead Group The PLC (LON:GOG), 10 have Buy rating, 2 Sell and 3 Hold. Therefore 67% are positive. Go-Ahead Group The PLC had 135 analyst reports since August 17, 2015 according to SRatingsIntel. Barclays Capital maintained it with “Equal Weight” rating and GBX 2667 target in Friday, January 8 report. RBC Capital Markets maintained Go-Ahead Group plc (LON:GOG) on Friday, June 23 with “Sector Performer” rating. The stock has “Neutral” rating by JP Morgan on Wednesday, May 24. The stock of Go-Ahead Group plc (LON:GOG) earned “Buy” rating by Canaccord Genuity on Thursday, December 15. The stock of Go-Ahead Group plc (LON:GOG) has “Hold” rating given on Monday, October 26 by Liberum Capital. The firm earned “Hold” rating on Monday, March 6 by Liberum Capital. The stock has “Buy” rating by Investec on Thursday, June 22. As per Friday, April 21, the company rating was maintained by JP Morgan. Deutsche Bank maintained it with “Buy” rating and GBX 2340 target in Tuesday, January 31 report. The stock of Go-Ahead Group plc (LON:GOG) earned “Overweight” rating by JP Morgan on Monday, September 5. See Go-Ahead Group plc (LON:GOG) latest ratings:

08/11/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1810.00 New Target: GBX 1810.00 Maintain
03/11/2017 Broker: HSBC Rating: Buy Old Target: GBX 1940.00 New Target: GBX 1940.00 Maintain
22/09/2017 Broker: Jefferies Rating: Buy Old Target: GBX 2425.00 New Target: GBX 2070.00 Maintain
20/09/2017 Broker: HSBC Rating: Buy Old Target: GBX 1970.00 New Target: GBX 1940.00 Maintain
11/09/2017 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 2350.00 New Target: GBX 2080.00 Reiteration
08/09/2017 Broker: JP Morgan Rating: Underweight Old Target: GBX 1882.00 New Target: GBX 1355.00 Downgrade
08/09/2017 Broker: Jefferies Rating: Buy Old Target: GBX 2425.00 New Target: GBX 2425.00 Maintain
07/09/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1910.00 New Target: GBX 1910.00 Maintain
10/08/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1975.00 New Target: GBX 1910.00 Maintain
13/07/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1975.00 New Target: GBX 1975.00 Maintain

The stock of FibroGen Inc (NASDAQ:FGEN) is a huge mover today! About 320,358 shares traded. FibroGen Inc (NASDAQ:FGEN) has risen 52.86% since November 14, 2016 and is uptrending. It has outperformed by 36.16% the S&P500.The move comes after 8 months negative chart setup for the $3.60 billion company. It was reported on Nov, 14 by Barchart.com. We have $40.78 PT which if reached, will make NASDAQ:FGEN worth $252.00M less.

The Go-Ahead Group plc is a United Kingdom public passenger transport firm for bus and rail services. The company has market cap of 724.15 million GBP. The Group operates through three divisions: regional bus, London bus and rail. It has a 8.11 P/E ratio. The regional bus segment comprises commercial bus businesses outside of London.

The stock decreased 0.34% or GBX 5.8 on November 14, reaching GBX 1679.2. About 61,178 shares traded. Go-Ahead Group plc (LON:GOG) has 0.00% since November 14, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts await FibroGen Inc (NASDAQ:FGEN) to report earnings on March, 7. They expect $-0.28 earnings per share, up 48.15% or $0.26 from last year’s $-0.54 per share. After $-0.50 actual earnings per share reported by FibroGen Inc for the previous quarter, Wall Street now forecasts -44.00% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>